Page 10 - Mitchell Warren News Today

World news and latest global news headlines from Africa, Asia, Middle east and United states

The injectable option will be taken by at-risk people at intervals of two months

Research from clinical trials that were published last year showed better results from the injectable PrEP compared to the oral pills

People at risk of getting HIV will now have an injectable option for pre-exposure prophylaxis (Prep) after the US regulator approved its use in adults and adole

The federal Food and Drug Administration has approved Apretude (extended-release cabotegravir), the first long-acting injectable option for HIV prevention.

The federal Food and Drug Administration has approved Apretude (extended-release cabotegravir), the first long-acting injectable option for HIV prevention.

Apretude is administered every 2 months versus a daily pill

In the U.S., women account for a fifth of new infections. But a persistent lack of education means few even know about the highly effective medication known as PrEP.

In the U.S., women account for a fifth of new infections. But a persistent lack of education means few even know about the highly effective medication known as PrEP.

Researchers plan to use a series of shots to teach people’s immune systems to produce powerful antibody responses against the virus.